Medical Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC PatientsBy Marie JonesJuly 28, 2023 OMO-103 in Phase 1b clinical trial Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for cancer…
